MIRA INFORM REPORT

 

 

Report Date :

05.11.2011

 

IDENTIFICATION DETAILS

 

Name :

IBSA INSTITUT BIOCHIMIQUE SA

 

 

Registered Office :

Via del Piano 6915 Pambio-Noranco

 

 

Country :

Switzerland

 

 

Year of Establishment :

1939

 

 

Com. Reg. No.:

514.3.000.824-0 / 85345

 

 

Legal Form :

Company limited by shares

 

 

Line of Business :

The company develops, produces and sells is specialisted pharmaceutical products

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

CHF 1'000'000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

Switzerland

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Company name and address

 

IBSA Institut Biochimique SA

 

Operating address:

Via del Piano                                                                IBSA Manufacturing and Technical Operations

6915 Pambio-Noranco                                                   Via al Ponte 13

Switzerland/CH                                                             6900 Massagno

                                                                                   Switzerland/CH

 

Telephone:                    058 3601000                             058 3601000

Fax:                             058 3601686                             058 3601228

 

Web site:                      http://www.ibsa.ch

E-mail:                         info@ibsa.ch

 

VAT-No.:                      CHE-102.243.028

 

 

Profile

 

Established:                  1939

Line of Business:           Pharmaceutics

Industry Division:           Manufacturing

Industry-code (NACE):   2120       Manufacture of pharmaceutical preparations

Import/Export:               Export

Export sales:                80.0%

Banks:                         UBS Ltd

                                    CS Credit Suisse

                                    BSI

 

 

Operational Figures

 

Coverage:                     Company

Figures:                        approximately

Employees:                  550

Sales:                          CHF 100-200 Mio

 

 

Activity

 

The company develops, produces and sells is specialisted pharmaceutical products in Switzerland, in the EU and internationally. The products concentrate on the sectors endocrinology, sports medicines, dermatology and pneumology.

 

 

Real Estate

 

Information on property ownership was not available.

 

 

Company Register

 

Company No:                514.3.000.824-0 / 85345

Legal form:                    Company limited by shares

Registration:                 10.08.1945

Legal status:                 active

Responsible Register:    Registro di commercio del Cantone Ticino

Auditor:                        PricewaterhouseCoopers SA, Lugano

History:                        Date of Statutes: 01.09.1989

                                    Date of Incorporation Statutes: 10.08.1945

                                    Date of Statutes: 15.01.1997

 

Entry          Deleted      Name

active                           IBSA Institut Biochimique SA

active                           IBSA Biochemical Institute Ltd (Name translated)

active                           IBSA Biochemisches Institut AG (Name translated)

active                           IBSA Istituto Biochimico SA (Name translated)

 

Entry          Deleted      Legal domicile

active                           Massagno, Switzerland

 

Entry          Deleted      Address

12.05.2011                    Via al Ponte 13, 6900 Massagno/TI, Switzerland/CH

12.05.2011                    6903 Lugano/TI, Switzerland/CH (Postal address)

 

Entry          Deleted      Capital

20.01.1997                    Share Capital CHF 5'600'000, paidup CHF 5'600'000

 

Entry          Deleted      Capital Structure

20.01.1997                    22'400 Bearer shares of CHF 250.--

 

Entry          Deleted      Activity (original Language)

active                           Fabbricazione e smercio di specialità medicinali d'ogni genere; analisi di chimica medica, batteriologia, sierologia, immunologia, e ricerche scientifiche, nonché la creazione o la partecipazione al finanziamento di imprese similari e l'assunzione di operazioni e funzioni che hanno rapporto diretto od indiretto con il detto scopo principale.

 

Entry          Deleted      Remarks (original Language)

active                           Publishing authority: FUSC.

active                           Financial data: Compensazione credito di CHF 2'400'000.--.

active                           Financial data: Compensazione credito di CHF 400'000.--.

30.06.2008                    Contribution in kind/Asset takeover: Secondo contratto del 26.06.2008 la società ha trasferito attivi per CHF 16'497'902.-- e passivi verso terzi per CHF 12'092'218.-- alla neo-costituita IBSA International SA, in Collina d'Oro (CH-501.3.010.966-0). Contro prestazione: 1'000 azioni nominative da CHF 1'000.-- e un credito di CHF 2'905'684.-- nei confronti della neo-costituita società.

 

Entry          Deleted      Branches

20.12.2007                    Via Dogana Vecchia 2, 6900 Lugano/TI, Switzerland/CH (Business place)

06.06.2002                    Stabile Vedeggio, 6928 Manno/TI, Switzerland/CH (Business place)

06.06.2002                    Località Serta, 6814 Lamone/TI, Switzerland/CH (Business place)

06.06.2002                    Via Violino 3, 6928 Manno/TI, Switzerland/CH (Business place)

06.06.2002                    Via del Piano, 6915 Pambio-Noranco/TI, Switzerland/CH (Business place)

 

 

Official Administration

 

Title                                           Name

President & Chief Executive          Dr. Arturo Licenziati, Origin: Italy, Address: Canobbio, Switzerland, single signature

Executive Director                        Giuseppe Ambrosetti, Origin: Bodio, Switzerland, Address: Ponte Capriasca/TI, Switzerland, joint signature of two, Appointment: 24.03.2009

Executive Director                        Dr. Enzo Tognola, Origin: Biasca, Switzerland, Address: Minusio, Switzerland, joint signature of two

 

 

Management

 

Title                                           Name

Member with procuration              Dr. Franco Daglio, Origin: Italy, Address: Lugano/TI, Switzerland, joint power of attorney of two

Member with procuration              Dr. Antonio Melli, Origin: Italy, Address: Capiago/CO, Italy, joint power of attorney of two

Member with procuration              Luca Grassi, Origin: Italy, Address: 6983 Magliaso/TI, Switzerland, joint power of attorney of two

Member with procuration              Agnese Milesi, Origin: Onsernone, Switzerland, Address: Agno, Switzerland, joint power of attorney of two

Member with procuration              Romano D'Alessandro, Origin: Italy, Address: Agno, Switzerland, joint power of attorney of two

 

 

Executive board

 

Title                                           Name

Chief Executive Officer                 Dr. Arturo Licenziati

 

 

Ultimate Parent Company

 

Name:                          IBSA Holding SA

City/Country:                 Pambio-Noranco, Switzerland/CH

 

 

Owner/-s

 

Owner:                         The company is domestic owned.

 

Class:                          50-99%

Name:                          IBSA Holding SA

City/Country:                 Pambio-Noranco, Switzerland/CH

 

 

Sisters

 

Name:                          IBSA International SA

City/Country:                 Pambio-Noranco, Switzerland/CH

 

 

Investments

 

It is believed that the company has no investments.

 

 

Legal Actions

 

Control date       Year                       No.             Amount CHF     Status

13.06.2007          2007                           0

13.06.2007          2006                           0

13.06.2007          2005                           0

13.06.2007          2004                           0

13.06.2007          2003                           0

13.06.2007          2002                           0

13.06.2007          2001                           0

13.06.2007          2000                           0

 

An updated legal action check is only available against proof of interest. e.g. a copy of an enquiry letter, and order or invoice relating to the subject company.

 

 

Credit Information

 

Financial Statements:    The company does not disclose any financial statements. Third parties are not permitted any insight into the financial affairs. It is therefore difficult to make a proper assessment of the actual situation.

 

Financial Situation:        The financial situation is in order.

 

Payment experiences:   Financial obligations are met as appropriate.

 

Maximum Credit:           CHF 1'000'000.--

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.49.08

UK Pound

1

Rs.78.65

Euro

1

Rs.67.79

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.